GlassScriptPhysician profile
Robert W Thompson
NPI 1366432361
$2,203.95
in general payments reported to CMS, 2019-2025
24 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $107 · 2021: $318 · 2022: $330 · 2023: $335 · 2024: $167 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $310.00 | 2019-2025 | Rocklatan, Precision 1, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $276.27 | 2019-2025 | Acuvue |
| Abbvie INC. | $223.01 | 2025 | |
| Bausch & Lomb Americas INC. | $187.72 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $169.33 | 2019-2021 | |
| Oyster Point Pharma, INC. | $162.45 | 2022-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $110.70 | 2023-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $95.76 | 2021-2025 | Cequa |
| Thea Pharma INC. | $86.73 | 2023-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $84.05 | 2020-2022 | |
| Allergan, INC. | $78.32 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $59.27 | 2019-2020 | |
| Amgen INC. | $48.09 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $41.00 | 2024 | Xdemvy |
| Sight Sciences, INC. | $40.16 | 2020-2023 | Tearcare System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $39.78 | 2022 | |
| Plexus Optix, INC. | $38.12 | 2021 | |
| Abb Con-Cise Optical Group LLC | $37.67 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $27.61 | 2025 | Cirrus Hd-Oct |
| Dompe US, INC. | $24.48 | 2023 | Oxervate |
| Kala Pharmaceuticals, INC. | $23.18 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $14.65 | 2021 | |
| Alcon Research LLC | $14.41 | 2019 | |
| Topcon Healthcare, INC. | $11.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.